These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8291935)

  • 1. [Technetium TC 99m pyrophosphate myocardial scintigraphy in amyloidosis. Correlations with Doppler echocardiography].
    Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams A; Desgrez A; Blondeau M
    Arch Mal Coeur Vaiss; 1993 Jul; 86(7):1009-15. PubMed ID: 8291935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
    Gertz MA; Brown ML; Hauser MF; Kyle RA
    Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
    Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
    G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography.
    Fournier C; Grimon G; Rinaldi JP; Terral A; Boujon B; Adams D; Desgrez A; Blondeau M
    Am J Cardiol; 1993 Oct; 72(11):854-7. PubMed ID: 8213531
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.
    Eriksson P; Backman C; Bjerle P; Eriksson A; Holm S; Olofsson BO
    Br Heart J; 1984 Sep; 52(3):321-6. PubMed ID: 6087862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.
    Wizenberg TA; Muz J; Sohn YH; Samlowski W; Weissler AM
    Am Heart J; 1982 Apr; 103(4 Pt 1):468-73. PubMed ID: 6278906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
    Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
    Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
    [No Abstract]   [Full Text] [Related]  

  • 12. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocardial pyrophosphate uptake in cardiac amyloidosis: report of case].
    Redondo F; González P; Ramírez A
    Rev Med Chil; 2002 Mar; 130(3):315-8. PubMed ID: 12043375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial technetium-99m-pyrophosphate scintigraphy and echocardiography in the diagnosis of cardiac amyloidosis.
    Planinc D; Franceschi D; Zigman M; Jerić M; Pagon LJ; Mihatov S; Rudar M
    Acta Cardiol; 1992; 47(4):391-401. PubMed ID: 1387996
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is technetium-99 m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis?
    Hartmann A; Frenkel J; Hopf R; Baum RP; Hör G; Schneider M; Kaltenbach M
    Int J Card Imaging; 1990; 5(4):227-31. PubMed ID: 2172406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.
    Janssen S; Piers DA; van Rijswijk MH; Meijer S; Mandema E
    Eur J Nucl Med; 1990; 16(8-10):663-70. PubMed ID: 2166666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive detection and differentiation of cardiac amyloidosis using
    Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y
    Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
    Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
    Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
    Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS
    JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.